Media/Policy Watch

Media/Policy Watch
This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.

We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.

The Economist
http://www.economist.com/
Accessed 18 February 2017
International
Feb 16th 2017
Has philanthropy reached its limits? Podcast: The Economist asks Bill Gates
The Bill & Melinda Gates Foundation has given away grants of over $36 billion in the past decade. But under a new presidency, philanthropist and Microsoft co-founder Bill Gates faces stiff challenges on vaccine programmes, promised clampdowns on federal aid and a mood of distrust toward technocrats. He tells host Anne McElvoy why he still believes in engaging with Donald Trump

The Guardian
http://www.guardiannews.com/
Accessed 18 February 2017
Bill Gates warns tens of millions could be killed by bio-terrorism
Ewen MacAskill Defence correspondent in Munich
Saturday 18 February 2017 09.00 EST
Microsoft founder and philanthropist tells Munich security conference genetic engineering could be terrorist weapon

Scientific American
http://www.scientificamerican.com/
Accessed 18 February 2017
Guest Blog
Biting Back: Developing a Dengue Vaccine
We’ve been working on it for more than 70 years; here’s how we’re finally getting there, and what still needs to be done
By John Boslego on February 15, 2017
..The development of a safe and effective dengue vaccine candidate has faced many hurdles. An important challenge lies in the virus’s biological makeup. The dengue virus exists in four different forms, called serotypes. Each serotype can be transmitted from mosquito to human, and each can lead to dengue fever. The quest to develop a vaccine that protects against all four serotypes has proved challenging, compounded by the fact that infection by one serotype can lead to a more severe form of dengue fever upon re-infection by a different serotype (an effect called antibody-dependent enhancement). Moreover, multiple serotypes are present in many of the 128 countries where dengue is endemic. This means we must ensure that vaccination is protective against all four serotypes.
New dengue vaccine candidates, including the one I oversee at Takeda’s global vaccine unit, are now in late-stage, Phase 3 clinical trials. The TIDES Phase 3 trial is evaluating safety of the vaccine candidate, as well as efficacy in protecting study subjects against dengue caused by any of the four virus serotypes. If successful, it will be another victory in the collective effort against mosquito-borne diseases…
John Boslego is Senior Vice President and Head of Development for Takeda Pharmaceuticals Global Vaccine Business Unit

Wall Street Journal
http://www.online.wsj.com/home-page?_wsjregion=na,us&_homepage=/home/us
Accessed 18 February 2017
Italy’s Vaccination Rates Raise Government’s Concern
Measles inoculations have dipped below level of India amid stubborn antivaccine sentiment
13 February 2017
By Pietro Lombardi
Italy is the latest front in Europe’s growing antivaccine trend, fueled in part by groups that oppose mandatory injections and raise doubts over their safety. The share of Italian 1-year-olds immunized against measles has dropped by at least 5 percentage points since 2012, according to the World Health Organization, slipping below the comparable rate for India. The country’s 2015 immunization rates were the lowest in Western Europe, WHO figures show, roughly on par with those in Serbia and Romania…

Washington Post
http://www.washingtonpost.com/
Accessed 18 February 2017
Fact Checker
Analysis
Trump’s claim that there’s ‘tremendous amount of increase’ in autism cases
By Michelle Ye Hee Lee February 16, 2017